PLx Pharma

• Founded

  14 Jan 2010

Sources: search.gleif.org

• NCT05055752

  Phase 1, Completed, 24 people, 24 Sept 2021

• NCT04008979

  Phase 1, Completed, 32 people, 5 Jul 2019

• NCT01646814

  Phase 2, Completed, 247 people, 20 Jul 2012

• NCT01515657

  Phase 3, Completed, 40 people, 24 Jan 2012

• Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers

  Phase 1/2, Completed, 204 people, 31 Mar 2009

Sources: clinicaltrials.gov